The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) poses a persistent threat to global public health. Although primarily a respiratory illness, extrapulmonary manifestations of COVID-19 include gastrointestinal, cardiovascular, renal and neurological diseases. Recent studies suggest that dysfunction of the endothelium during COVID-19 may exacerbate these deleterious events by inciting inflammatory and microvascular thrombotic processes. Although controversial, there is evidence that SARS-CoV-2 may infect endothelial cells by binding to the angiotensin-converting enzyme 2 (ACE2) cellular receptor using the viral Spike protein. In this review, we explore current insights into the relationship between SARS-CoV-2 infection, endothelial dysfunction due to ACE2 downregulation, and deleterious pulmonary and extra-pulmonary immunothrombotic complications in severe COVID-19. We also discuss preclinical and clinical development of therapeutic agents targeting SARS-CoV-2-mediated endothelial dysfunction. Finally, we present evidence of SARS-CoV-2 replication in primary human lung and cardiac microvascular endothelial cells. Accordingly, in striving to understand the parameters that lead to severe disease in COVID-19 patients, it is important to consider how direct infection of endothelial cells by SARS-CoV-2 may contribute to this process.

It has been suggested that gesture engrams, conceptual knowledge and/or the ability to infer function from structure can support object use. The present paper proposes an alternative view which is based upon the idea that object use requires solely the ability to reason about technical means provided by objects. Technical means are abstract principles which are not linked with any object representation (e.g., cutting involves the opposition between dense and permeable material). The technical reasoning model predicts that the inability to perform technical reasoning should impair performance in any situation requiring the use of objects (in a conventional way or not). Twenty left brain-damaged (LBD) patients, 11 right brain-damaged (RBD) patients and 41 healthy controls were examined on experimental tests assessing the conventional use of objects (e.g., screwing a screw with a screwdriver), conceptual knowledge about object function, pantomime of object use and recognition of object utilization gestures. We also designed the Unusual Use of Objects Test, which demands unusual applications of objects to achieve a purpose for which the usually applied object is not provided (e.g., screwing a screw with a knife). The key findings are that only LBD patients have more difficulties on the Unusual Use of Objects Test than controls or RBD patients, and that the severity of their impairment is correlated with that on conventional use of objects. Correlations with tests assessing conceptual knowledge as well as with tests of pantomime of object use and recognition of object utilization gestures were weaker. These results support the technical reasoning model and question the role of conceptual knowledge and gesture engrams in object use. Since the technical reasoning model also predicts two distinct technical disorders, the discussion focuses on the existence of these disorders in regard to individual performance profiles obtained in the Unusual Use of Objects Test.

No abstract

The activation of T cells requires the guanine nucleotide exchange factor VAV1. Using mice in which a tag for affinity purification was attached to endogenous VAV1 molecules, we analyzed by quantitative mass spectrometry the signaling complex that assembles around activated VAV1. Fifty VAV1-binding partners were identified, most of which had not been previously reported to participate in VAV1 signaling. Among these was CD226, a costimulatory molecule of immune cells. Engagement of CD226 induced the tyrosine phosphorylation of VAV1 and synergized with T cell receptor (TCR) signals to specifically enhance the production of interleukin-17 (IL-17) by primary human CD4 T cells. Moreover, co-engagement of the TCR and a risk variant of CD226 that is associated with autoimmunity (rs763361) further enhanced VAV1 activation and IL-17 production. Thus, our study reveals that a VAV1-based, synergistic cross-talk exists between the TCR and CD226 during both physiological and pathological T cell responses and provides a rational basis for targeting CD226 for the management of autoimmune diseases.

The guanine nucleotide exchange factor Vav1 is essential for transducing T cell antigen receptor signals and therefore plays an important role in T cell development and activation. Our previous genetic studies identified a locus on rat chromosome 9 that controls the susceptibility to neuroinflammation and contains a non-synonymous polymorphism in the major candidate gene Vav1. To formally demonstrate the causal implication of this polymorphism, we generated a knock-in mouse bearing this polymorphism (Vav1R63W). Using this model, we show that Vav1R63W mice display reduced susceptibility to experimental autoimmune encephalomyelitis (EAE) induced by MOG35-55 peptide immunization. This is associated with a lower production of effector cytokines (IFN-γ, IL-17 and GM-CSF) by autoreactive CD4 T cells. Despite increased proportion of Foxp3+ regulatory T cells in Vav1R63W mice, we show that this lowered cytokine production is intrinsic to effector CD4 T cells and that Treg depletion has no impact on EAE development. Finally, we provide a mechanism for the above phenotype by showing that the Vav1R63W variant has normal enzymatic activity but reduced adaptor functions. Together, these data highlight the importance of Vav1 adaptor functions in the production of inflammatory cytokines by effector T cells and in the susceptibility to neuroinflammation.

Alpha interferons (␣-IFNs

Heparin-affin regulatory peptide (HARP) and Midkine (MK) belong to a family of growth/differentiation factors that have a high affinity for heparin. The involvement of these molecules in various proliferative diseases prompted us to develop an assay for measuring the concentrations of these factors in biological fluids and culture media. This report describes an immunoassay that uses only commercially available materials, based on the high affinity of certain molecules for heparin. It consists of adsorbing heparin-BSA covalent complexes to microtiter plate wells and to quantify the heparin bound HARP or MK by using appropriate antibody. The method is specific and measures concentrations ranging from 40-1200 pg/mL HARP and from 25-1200 pg/mL MK and various parameters are investigated. The within-assay coefficient of variation was less than 5% for both assays. The method was checked by measuring the concentrations of these growth factors in the sera of healthy humans and in patients with cancer. As previously reported, we confirmed that the serum concentrations of MK are higher in patients with tumours (n = 139) than in controls (n = 19). The synthesis of HARP and MK by various cells in culture was also analysed.

Experimental allergic encephalomyelitis (EAE) is a T cell‐mediated autoimmune disease induced in susceptible rat strains by a single immunization with myelin basic protein (MBP). The Lewis (LEW) strain is susceptible to disease induction while the Brown Norway (BN) strain is resistant. This resistance involves non‐MHC genes since congenic BN‐1L rats, with LEW MHC on a BN‐derived background, are also resistant. In the present study we show that, upon immunization with MBP, the non‐MHC‐encoded resistance to develop clinical EAE in BN‐1L rats is associated with a decreased production of IFN‐γ. This may be due to a difference between LEW and BN‐1L rats in their ability to produce regulatory cytokines such as IL‐4, IL‐10 and TGF‐β. In comparison to LEW rats, immune lymph node cells from BN‐1L rats express an increased amount of IL‐4 mRNA but produce less IL‐10. Furthermore, the sera from BN‐1L rats contain higher amounts of active TGF‐β1. Therefore, we have investigated the involvement of IL‐4 and TGF‐β in the resistance of BN‐1L rats to develop EAE using neutralizing mAb. Neutralization of TGF‐β, but not IL‐4, renders BN‐1L rats susceptible to clinical EAEwithout affecting the proliferation or the cytokine repertoire of immune lymph node cells. With respect to the origin of the endogenous TGF‐β production, we excluded the involvement of CD8 T cells and discuss a possible role of platelets and of CD4 T cells exhibiting the CD45RClow phenotype.